0015

Ahn-Gook Pharmaceutical Co., Ltd. 001540

Market Closed
2 Oct, 06:30
KRX SM KRX SM
7,090. 00
-50
-0.7%
80.58B Market Cap
- P/E Ratio
880% Div Yield
7,579 Volume
- Eps
7,140.00
Previous Close
Day Range
7,040 7,160
Year Range
6,570 10,510

001540 Chart

Ahn-Gook Pharmaceutical Co., Ltd. Profile

Drug Manufacturers - Specialty & Generic Industry
Healthcare Sector
- CEO
KRX SM Exchange
- ISIN
South Korea Country
404 Employees
- Last Dividend
29 Dec 2014 Last Split
- IPO Date

Overview

Ahn-Gook Pharmaceutical Co., Ltd. is an established player in the pharmaceutical industry, founded in 1959 and strategically headquartered in Seoul, South Korea. The company has carved out a niche in the manufacturing and marketing of pharmaceutical products, consolidating its presence both domestically and on the international stage. Its commitment to improving human health and its relentless pursuit of innovation and quality has positioned Ahn-Gook Pharmaceutical as a trusted brand among healthcare professionals and patients alike. With a history spanning over six decades, the company continues to lead with its forward-thinking approaches, adapting to the evolving healthcare landscape and expanding its product portfolio to meet the varied needs of the global market.

Products and Services

  • Cinatura: This is one of the flagship products of Ahn-Gook Pharmaceutical, known for its effectiveness in managing certain medical conditions. As a proprietary medicine, Cinatura represents the company’s commitment to research and development, showcasing their ability to create innovative solutions for health care challenges.
  • Revo Tension: Another prominent offering, Revo Tension, underscores Ahn-Gook Pharmaceutical's prowess in addressing cardiovascular diseases. Designed to help patients manage blood pressure, this medication is a testament to the company's dedication to contributing to the global fight against hypertension and related conditions.

In addition to these products, Ahn-Gook Pharmaceutical Co., Ltd. continually invests in the development of new pharmaceuticals and healthcare solutions. With a robust R&D infrastructure, the company is able to extend its product lines to include treatments for a variety of ailments, thereby enhancing patient care and improving quality of life on a global scale.

Contact Information

Address: 613 Siheung -daero
Phone: 82 2 3289 4226